Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 8/20 | 0.54 |
| ▸ | CTSB | P07858 | 3/20 | 0.51 |
| ▸ | CALCRL | Q16602 | 5/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.44 |
| ▸ | GRB2 | P62993 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29379577 | 0.83 | GRB2 (0.50) | CAPN1GRB2 | |
| SCHEMBL30368248 | 0.83 | CALCRL (0.49) | CAPN1CALCRLSLC6A2KEAP1GRB2 | |
| SCHEMBL9068934 | 0.83 | CALCRL (0.52) | CAPN1CTSBCALCRLSLC6A2KEAP1 | |
| SCHEMBL30973997 | 0.82 | CAPN1 (0.55) | CAPN1CTSBCALCRLSLC6A2GRB2 | |
| SCHEMBL9082723 | 0.82 | CALCRL (0.55) | CAPN1CTSBCALCRLSLC6A2KEAP1 | |
| SCHEMBL14199456 | 0.82 | CAPN1 (0.47) | CAPN1CTSBCALCRLSLC6A2 | |
| SCHEMBL9534467 | 0.82 | EPHA2 (0.48) | CAPN1CTSBSLC6A2GRB2 | |
| SCHEMBL29947945 | 0.82 | XIAP (0.53) | CAPN1GRB2 | |
| SCHEMBL29531054 | 0.80 | SLC6A2 (0.47) | CAPN1CTSBCALCRLSLC6A2KEAP1 | |
| SCHEMBL30974008 | 0.80 | ACE (0.54) | CAPN1CALCRLSLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118286126-A | Dressing for treating facial or body surfaces | ELC 管理有限责任公司 | 2024-07-05 | — | — | CN | disclosed |
| EP-3554470-B1 | COSMETIC COMPOSITIONS COMPRISING HYALURONIC ACID | ELC MAN LLC (US) | 2023-07-26 | — | — | EP | disclosed |
| CN-110381775-B | Packaging for skin treatment compositions and method of applying treatment compositions | ELC 管理有限责任公司 | 2022-11-01 | — | — | CN | disclosed |
| US-11291286-B2 | Cosmetic compositions with a micro-mesh structure | ELC MANAGEMENT LLC (US) | 2022-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11291286-B2 | Cosmetic compositions with a micro-mesh structure | CD44, CUTA, MSH6 | CAPN1 3855/4885CTSB 1494/4885CALCRL 3983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.